483 Merck Sharp & Dohme May 2002

483 Merck Sharp & Dohme May 2002

Ann Demarco FDA, Ann Montemurro FDA, Paula Trost FDA$595.00 - Available Now

FDA investigators audited the Merck Sharp & Dohme - West Point, PA, United States facility and issued inspectional observations (via FDA 483) on 03 May 2002.

Product details

  • Category: Human Drugs / Biologics
  • Inspection end: 03 May 2002
  • Location: West Point, United States
  • FEI: 2510592
Add To Cart